
<document id="DBMI.pac106" origId="pac106">
	<sentence id="DBMI.pac106.s0" origId="s0" text="7 DRUG INTERACTIONS\n\n7.1 Catecholamine Depleting Drugs\n\nCatecholamine depleting drugs (eg, reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents."/>
	<sentence id="DBMI.pac106.s1" origId="s1" text="Observe patients treated with TOPROL-XL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension."/>
	<sentence id="DBMI.pac106.s2" origId="s2" text="7.2 CYP2D6 Inhibitors\n\nDrugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration.">
		<entity charOffset="444-454" id="DBMI.pac106.s2.e0" origId="s2.e0" text="quinidine " type="Active ingredient"/>
		<entity charOffset="518-529" id="DBMI.pac106.s2.e1" origId="s2.e1" text="metoprolol " type="Active ingredient"/>
		<entity charOffset="455-466" id="DBMI.pac106.s2.e2" origId="s2.e2" text="fluoxetine " type="Active ingredient"/>
		<entity charOffset="467-478" id="DBMI.pac106.s2.e3" origId="s2.e3" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="483-495" id="DBMI.pac106.s2.e4" origId="s2.e4" text="propafenone " type="Active ingredient"/>
		<pair e1="DBMI.pac106.s2.e0" e2="DBMI.pac106.s2.e1" id="DBMI.pac106.s2.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="quinidine "/>
		<pair e1="DBMI.pac106.s2.e0" e2="DBMI.pac106.s2.e2" id="DBMI.pac106.s2.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e0" e2="DBMI.pac106.s2.e3" id="DBMI.pac106.s2.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e0" e2="DBMI.pac106.s2.e4" id="DBMI.pac106.s2.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e1" e2="DBMI.pac106.s2.e0" id="DBMI.pac106.s2.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e1" e2="DBMI.pac106.s2.e2" id="DBMI.pac106.s2.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e1" e2="DBMI.pac106.s2.e3" id="DBMI.pac106.s2.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e1" e2="DBMI.pac106.s2.e4" id="DBMI.pac106.s2.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e2" e2="DBMI.pac106.s2.e0" id="DBMI.pac106.s2.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e2" e2="DBMI.pac106.s2.e1" id="DBMI.pac106.s2.p9" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="fluoxetine "/>
		<pair e1="DBMI.pac106.s2.e2" e2="DBMI.pac106.s2.e3" id="DBMI.pac106.s2.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e2" e2="DBMI.pac106.s2.e4" id="DBMI.pac106.s2.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e3" e2="DBMI.pac106.s2.e0" id="DBMI.pac106.s2.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e3" e2="DBMI.pac106.s2.e1" id="DBMI.pac106.s2.p13" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="paroxetine "/>
		<pair e1="DBMI.pac106.s2.e3" e2="DBMI.pac106.s2.e2" id="DBMI.pac106.s2.p14" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e3" e2="DBMI.pac106.s2.e4" id="DBMI.pac106.s2.p15" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e4" e2="DBMI.pac106.s2.e0" id="DBMI.pac106.s2.p16" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e4" e2="DBMI.pac106.s2.e1" id="DBMI.pac106.s2.p17" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="propafenone "/>
		<pair e1="DBMI.pac106.s2.e4" e2="DBMI.pac106.s2.e2" id="DBMI.pac106.s2.p18" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.s2.e4" e2="DBMI.pac106.s2.e3" id="DBMI.pac106.s2.p19" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac106.s3" origId="s3" text="In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life.">
		<entity charOffset="629-639" id="DBMI.pac106.s3.e0" origId="s3.e0" text="quinidine " type="Active ingredient"/>
		<entity charOffset="668-679" id="DBMI.pac106.s3.e1" origId="s3.e1" text="metoprolol " type="Active ingredient"/>
		<pair e1="DBMI.pac106.s3.e0" e2="DBMI.pac106.s3.e1" id="DBMI.pac106.s3.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="metoprolol " precipitant="quinidine "/>
		<pair e1="DBMI.pac106.s3.e1" e2="DBMI.pac106.s3.e0" id="DBMI.pac106.s3.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac106.s4" origId="s4" text="In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d.with immediate-release metoprolol 50 mg t.i.d.resulted in two- to five-fold increases in the steady-state concentration of metoprolol.">
		<entity charOffset="844-856" id="DBMI.pac106.s4.e0" origId="s4.e0" text="propafenone " type="Active ingredient"/>
		<entity charOffset="893-904" id="DBMI.pac106.s4.e1" origId="s4.e1" text="metoprolol " type="Active ingredient"/>
		<pair e1="DBMI.pac106.s4.e0" e2="DBMI.pac106.s4.e1" id="DBMI.pac106.s4.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="metoprolol " precipitant="propafenone "/>
		<pair e1="DBMI.pac106.s4.e1" e2="DBMI.pac106.s4.e0" id="DBMI.pac106.s4.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac106.s5" origId="s5" text="These increases in plasma concentration would decrease the cardioselectivity of metoprolol."/>
	<sentence id="DBMI.pac106.s6" origId="s6" text="7.3 Digitalis, Clonidine, and Calcium Channel Blockers\n\nDigitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate."/>
	<sentence id="DBMI.pac106.s7" origId="s7" text="Concomitant use with beta blockers can increase the risk of bradycardia."/>
	<sentence id="DBMI.pac106.s8" origId="s8" text="If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine."/>
	<sentence id="DBMI.pac106.s9" origId="s9" text="If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped [see Warnings and Precautions(5.11)]. "/>
	<sentencespan id="DBMI.pac106.sp0" origId="sp0" text="7 DRUG INTERACTIONS\n\n7.1 Catecholamine Depleting Drugs\n\nCatecholamine depleting drugs (eg, reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents. Observe patients treated with TOPROL-XL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension. 7.2 CYP2D6 Inhibitors\n\nDrugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration.">
		<entity charOffset="444-454" id="DBMI.pac106.sp0.e0" origId="sp0.e0" text="quinidine " type="Active ingredient"/>
		<entity charOffset="518-529" id="DBMI.pac106.sp0.e1" origId="sp0.e1" text="metoprolol " type="Active ingredient"/>
		<entity charOffset="455-466" id="DBMI.pac106.sp0.e2" origId="sp0.e2" text="fluoxetine " type="Active ingredient"/>
		<entity charOffset="467-478" id="DBMI.pac106.sp0.e3" origId="sp0.e3" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="483-495" id="DBMI.pac106.sp0.e4" origId="sp0.e4" text="propafenone " type="Active ingredient"/>
		<pair e1="DBMI.pac106.sp0.e0" e2="DBMI.pac106.sp0.e1" id="DBMI.pac106.sp0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="quinidine "/>
		<pair e1="DBMI.pac106.sp0.e0" e2="DBMI.pac106.sp0.e2" id="DBMI.pac106.sp0.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e0" e2="DBMI.pac106.sp0.e3" id="DBMI.pac106.sp0.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e0" e2="DBMI.pac106.sp0.e4" id="DBMI.pac106.sp0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e1" e2="DBMI.pac106.sp0.e0" id="DBMI.pac106.sp0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e1" e2="DBMI.pac106.sp0.e2" id="DBMI.pac106.sp0.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e1" e2="DBMI.pac106.sp0.e3" id="DBMI.pac106.sp0.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e1" e2="DBMI.pac106.sp0.e4" id="DBMI.pac106.sp0.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e2" e2="DBMI.pac106.sp0.e0" id="DBMI.pac106.sp0.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e2" e2="DBMI.pac106.sp0.e1" id="DBMI.pac106.sp0.p9" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="fluoxetine "/>
		<pair e1="DBMI.pac106.sp0.e2" e2="DBMI.pac106.sp0.e3" id="DBMI.pac106.sp0.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e2" e2="DBMI.pac106.sp0.e4" id="DBMI.pac106.sp0.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e3" e2="DBMI.pac106.sp0.e0" id="DBMI.pac106.sp0.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e3" e2="DBMI.pac106.sp0.e1" id="DBMI.pac106.sp0.p13" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="paroxetine "/>
		<pair e1="DBMI.pac106.sp0.e3" e2="DBMI.pac106.sp0.e2" id="DBMI.pac106.sp0.p14" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e3" e2="DBMI.pac106.sp0.e4" id="DBMI.pac106.sp0.p15" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e4" e2="DBMI.pac106.sp0.e0" id="DBMI.pac106.sp0.p16" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e4" e2="DBMI.pac106.sp0.e1" id="DBMI.pac106.sp0.p17" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="metoprolol " precipitant="propafenone "/>
		<pair e1="DBMI.pac106.sp0.e4" e2="DBMI.pac106.sp0.e2" id="DBMI.pac106.sp0.p18" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp0.e4" e2="DBMI.pac106.sp0.e3" id="DBMI.pac106.sp0.p19" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac106.sp1" origId="sp1" text="In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life. In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d.with immediate-release metoprolol 50 mg t.i.d.resulted in two- to five-fold increases in the steady-state concentration of metoprolol. These increases in plasma concentration would decrease the cardioselectivity of metoprolol.">
		<entity charOffset="629-639" id="DBMI.pac106.sp1.e0" origId="sp1.e0" text="quinidine " type="Active ingredient"/>
		<entity charOffset="668-679" id="DBMI.pac106.sp1.e1" origId="sp1.e1" text="metoprolol " type="Active ingredient"/>
		<entity charOffset="844-856" id="DBMI.pac106.sp1.e2" origId="sp1.e2" text="propafenone " type="Active ingredient"/>
		<pair e1="DBMI.pac106.sp1.e0" e2="DBMI.pac106.sp1.e1" id="DBMI.pac106.sp1.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="metoprolol " precipitant="quinidine "/>
		<pair e1="DBMI.pac106.sp1.e0" e2="DBMI.pac106.sp1.e2" id="DBMI.pac106.sp1.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp1.e1" e2="DBMI.pac106.sp1.e0" id="DBMI.pac106.sp1.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp1.e1" e2="DBMI.pac106.sp1.e2" id="DBMI.pac106.sp1.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp1.e2" e2="DBMI.pac106.sp1.e0" id="DBMI.pac106.sp1.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac106.sp1.e2" e2="DBMI.pac106.sp1.e1" id="DBMI.pac106.sp1.p5" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="metoprolol " precipitant="propafenone "/>
	</sentencespan>
	<sentencespan id="DBMI.pac106.sp2" origId="sp2" text="7.3 Digitalis, Clonidine, and Calcium Channel Blockers\n\nDigitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. Concomitant use with beta blockers can increase the risk of bradycardia. If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine."/>
	<sentencespan id="DBMI.pac106.sp3" origId="sp3" text="If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped [see Warnings and Precautions(5.11)]. "/>
</document>
